Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Christopher W. Dukes"'
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients
Autor:
Christopher W. Dukes, Marine Potez, Jeffrey Lancet, Barbara J. Kuter, Junmin Whiting, Qianxing Mo, Brett Leav, Haixing Wang, Julie S. Vanas, Christopher L. Cubitt, Kimberly Isaacs-Soriano, Kayoko Kennedy, Julie Rathwell, Julian Diaz Cobo, Wesley O’Nan, Bradley Sirak, Ning Dong, Elaine Tan, Patrick Hwu, Anna R. Giuliano, Shari Pilon-Thomas
Publikováno v:
Vaccines, Vol 12, Iss 1, p 13 (2023)
Cancer patients are at an increased risk of morbidity and mortality from SARS-CoV-2 infection and have a decreased immune response to vaccination. We conducted a study measuring both the neutralizing and total antibodies in cancer patients following
Externí odkaz:
https://doaj.org/article/ededf2521f284d438b64ae90e00b4c51
Autor:
Anna R. Giuliano, Shari Pilon-Thomas, Michael J. Schell, Martha Abrahamsen, Jessica Y. Islam, Kimberly Isaacs-Soriano, Kayoko Kennedy, Christopher W. Dukes, Junmin Whiting, Julie Rathwell, Jonathan A. Hensel, Leslie N. Mangual, Ernst Schonbrunn, Melissa Bikowitz, Dylan Grassie, Yan Yang
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 3, Pp 556-563 (2022)
Estimating the actual extent of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic is challenging because virus test positivity data undercount the actual number and proportion of persons infected. SARS-CoV-2 seroprevalence is
Externí odkaz:
https://doaj.org/article/f893baf41fe34062a178042940e84337
Autor:
Corey Gallen, Christopher W. Dukes, Amy Aldrich, Lauren Macaisa, Qianxing Mo, Christopher L. Cubitt, Shari Pilon-Thomas, Anna R. Giuliano, Brian J. Czerniecki, Ricardo L. B. Costa
Publikováno v:
Vaccines, Vol 10, Iss 11, p 1931 (2022)
We conducted a prospective study to evaluate immune responses to SARS-CoV-2 in oncology workers in which we collected blood and clinical data every 6 months. Spike-specific CD4+ T-cells and immunoglobulin G responses were measured using interferon-ga
Externí odkaz:
https://doaj.org/article/27670b1d4b5f4bdf92fba4684012f681
Autor:
Corey, Gallen, Christopher W, Dukes, Amy, Aldrich, Lauren, Macaisa, Qianxing, Mo, Christopher L, Cubitt, Shari, Pilon-Thomas, Anna R, Giuliano, Brian J, Czerniecki, Ricardo L B, Costa
Publikováno v:
Vaccines. 10(11)
We conducted a prospective study to evaluate immune responses to SARS-CoV-2 in oncology workers in which we collected blood and clinical data every 6 months. Spike-specific CD4
Autor:
Anna R. Giuliano, Jeffrey E. Lancet, Shari Pilon-Thomas, Ning Dong, Akriti G. Jain, Elaine Tan, Somedeb Ball, Shelley S. Tworoger, Erin M. Siegel, Junmin Whiting, Qianxing Mo, Christopher L. Cubitt, Christopher W. Dukes, Jonathan A. Hensel, Robert J. Keenan, Patrick Hwu
Publikováno v:
JAMA Oncology. 8:748
Patients with cancer experience high rates of morbidity and mortality after SARS-CoV-2 infection. Immune response to mRNA-1273 vaccination across multiple cancer types and treatments remains to be established.To quantitate antibody responses after mR
Autor:
Joseph Markowitz, Shari Pilon-Thomas, Amod A Sarnaik, Pei-ling Chen, Ahmad A Tarhini, Zeynep Eroglu, Andrew S Brohl, Nikhil I Khushalani, Vernon K Sondak, Youngchul Kim, Michael Shamblott, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward Garcia, Ashraf Delhawi, Deanryan BDe Aquino, Patricia Lawman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/9bd031bd3186447cb187adb5c94e6559
Autor:
Christopher W Dukes, Renata AM Rossetti, Jonathan A Hensel, Sebastian Snedal, Christopher L Cubitt, Michael J Schell, Martha Abrahamsen, Kimberly Isaacs-Soriano, Kayoko Kennedy, Leslie N Mangual, Junmin Whiting, Veronica Martinez-Brockhus, Jessica Y Islam, Julie Rathwell, Matthew Beatty, Amy M Hall, Daniel Abate-Daga, Anna R Giuliano, Shari Pilon-Thomas
Publikováno v:
Journal of Clinical Virology Plus, Vol 3, Iss 3, Pp 100158- (2023)
Background: The role of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) neutralizing antibody response from natural infection and vaccination, and the potential determinants of this response are poorly understood. Characterizing this
Externí odkaz:
https://doaj.org/article/3b1528d0197246a3b73884009294ee6d